The All-In-One Guru Screener, can be used to find the most insider buys over the past week by clicking on the "Insiders" tab and changing the settings for All Insider Buying to "500,000+ shares at $2,000,000" and Duration to "over the past 7 days."
Crbylan Therapeutics Inc (CBYL) and COSI Inc (COSI) were the two companies with the heaviest buys over the past week that met the criteria.
On April 14, CBYL was bought by 5 insiders. Two directors (NOHR GUY P and CHA ALBERT) and three 10% owners (ACMP IV LLC, InterWest Management Partners and Vivo Ventures VI, LLC) bought a total of 4,590,000 shares with a total cost of $22,950,000 at an average price of $5.00 per share. Since then, the price rose by 7.8%.
CBYL has a market cap of $131 million and is engaged in the development and commercialization of novel and proprietary combination therapies that address significant unmet medical needs. It develops Hydros-TA, its proprietary intra-articular injectable product candidate to treat pain associated with osteoarthritis of the knee. The company is developing Hydros-TA in its COR1.1 trial, a Phase 3, multi-center, international, randomized, double-blind, three-arm trial enrolling up to 510 patients with grade two and grade three OA of the knee, comparing treatment with Hydros-TA to treatment with Hydros and with TA, on a standalone basis.
The company has a good financial strength even if cash to debt ratio (0.11) is at the worst levels of CBYL's history. Profitability & Growth is rated 5/10 with ratios better then 90% of competitors (8.53% of ROE, 4.70% of ROA, 9.23% of ROC).
The hedge fund Broadfin Capital filled a new 5.2% passive position in CBYL. Broadfin is the first investor to file a position that consists of 1.25 million shares.
On April 10, the 10% owner, Plaisance Fund LP, purchased 1,757,609 shares of COSI, with a total cost of $3,796,440. Since then, the price rose by 21.8%.
COSI has an Institutional Ownership of 11% and an Insider Ownership of 25%.
COSI has a market cap of $101 million and over the last year, the price rose by 121% and is currently trading at a P/B ratio of 8.10, that is ranked lower than 59% of other companies in the Global Restaurants industry that has an average P/B of 4.30.
The company has negative returns, ROE of -968.26% and ROA of -82.26% with a profitability and growth rated 2/10 and a financial situation rated 1/10 even if cash to debt ratio is 3.26.
Gurus Jim Simons and Chuck Royce traded this company during the last 5 years but since 2014 Q3, the company is not held by any Guru.
